Virtual Salon - July 28: Ophthalmic Drug Delivery: Eye on Innovation

Ophthalmic Drug Delivery: Eye on Innovation

Innovative biotech companies are racing to develop unique drug-delivery systems and agents that overcome the many obstacles that have limited the treatment of serious and increasingly common eye problems. Our panelists will outline the trajectory of this industry’s growth and give an overview of the technologies that are advancing it. Many new ocular drug-transport systems and formulations are being designed as noninvasive, early, and more patient-friendly treatments. Our panelists will also provide insight into bringing these treatments from lab to clinical study and market.

The Demy-Colton Virtual Salon Series brings cutting-edge insights from key opinion leaders in the life sciences and digital health industry. The webinar-based channels include Therapies/Technologies, Master Class Series - C-Suite, Thought Leader Interviews, Business and Finance, and Humans vs Machines: The Trial Prediction Challenge Series.

Moderator: 

• Laura Randa, Co-Chair Executive Women in Bio, Capital Region, Women in Bio

Panelists:

• Kerrie Brady, CEO, President & Board Member, OcuTerra Therapeutics
• Jeffrey L. Cleland, PhD, Chairman, CEO, President & Co-Founder, Ashvattha Therapeutics, LLC
• Mina Sooch, President & CEO, Ocuphire

Hosted by Sara Jane Demy, CEO of Demy-Colton, this informative panel is part of the Demy-Colton Virtual Salon Series. 

Please click here to register.